PharmGen Science Market Cap

PharmGen Science has a market cap or net worth of 73.64 billion as of April 17, 2025. Its market cap has decreased by -30.00% in one year.

Market Cap

73.64B

Enterprise Value

74.17B

Revenue

171.29B

Ranking

n/a

PE Ratio

26.63

Stock Price

3,950.00

Market Cap Chart

Since August 31, 1995, PharmGen Science's market cap has increased from 10.89B to 73.64B, an increase of 576.06%. That is a compound annual growth rate of 6.66%.

Market Cap History

Date	Market Cap	% Change
Apr 17, 2025	74.18B	0.00%
Dec 30, 2024	74.18B	-33.39%
Dec 28, 2023	111.36B	5.58%
Dec 29, 2022	105.47B	-33.88%
Dec 30, 2021	159.51B	-3.78%
Dec 30, 2020	165.78B	123.51%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	74.66T
Celltrion	33.89T
ALTEOGEN	20.94T
Yuhan	8,636.87B
SK Biopharmaceuticals	8,207.23B
HLB Co., Ltd.	7,214.15B
Peptron	4,195.85B
LigaChem Biosciences	3,958.37B

Market Cap Rankings